Adamas Pharmaceuticals' IPO

Adamas Pharmaceuticals raised a round of funding on April 10, 2014. Investors include Public.

Adamas, formerly NeuroMolecular Pharmaceuticals, is a pharmaceutical company focused on developing small molecule, advantaged therapeutics to treat neurological and infectious diseases, including infl…

Articles about Adamas Pharmaceuticals' IPO: